scholarly journals Multilayered Extended Release Tablet Dosage Form

2020 ◽  
Author(s):  
2004 ◽  
Vol 58 (3) ◽  
pp. 607-614 ◽  
Author(s):  
Yaw-Bin Huang ◽  
Yi-Hung Tsai ◽  
Wan-Chiech Yang ◽  
Jui-Sheng Chang ◽  
Pao-Chu Wu ◽  
...  

2021 ◽  
pp. 1-3
Author(s):  
Farzad Khajavi ◽  

Formulation of Ranolazine in the form of extended-release tablet in 500 mg dosage form was performed using Eudragit L100-55 as a retarding agent. Drugrelease profiles were investigated in comparison with the reference Ranexa extended-release 500 mg tablet. F2 and f1 were calculated as 64.16 and 8.53, respectively. According to Peppas equation, the release of drug is controlled by diffusion (n=0.5). The tablets were put into accelerated stability condition (40⁰C, 75% humidity) for 3 and 6 months. The dissolution release profiles and other physical and chemical characteristics of the tablets confirmed the robustness and stability of formulation in this condition.


2010 ◽  
Vol 383 (1-2) ◽  
pp. 99-105 ◽  
Author(s):  
Shinichiro Tajiri ◽  
Taro Kanamaru ◽  
Kamada Makoto ◽  
Tsutomu Konno ◽  
Hiroaki Nakagami

2015 ◽  
Vol 35 (5) ◽  
pp. 291-297 ◽  
Author(s):  
Mona Darwish ◽  
Ronghua Yang ◽  
William Tracewell ◽  
Philmore Robertson ◽  
Mary Bond

Sign in / Sign up

Export Citation Format

Share Document